XYL
Company Description
Xylem Inc. is a global leader in water cycle technologies, with $9.04 billion in revenue in 2025 and operations in more than 150 countries. It operates through three main segments: Water Infrastructure pumps and treatment for municipal and industrial customers , Applied Water solutions for commercial and residential distribution networks , and Measurement & Control Solutions sensors, analytics and smart water networks . The acquisition of Evoqua in 2023 significantly expanded its advanced water treatment capabilities. Listed on the NYSE, the company is headquartered in Washington D.C. GICS sector: Industrials β Machinery.General Overview
| Field | Value |
|---|---|
| Price | $121.68 (23/04/2026, 09:46 ET / 15:46 CET) |
| Country | United States |
| Exchange | NYSE |
| GICS Sector | Industrials β Machinery |
| Type | GROWTH |
| Market Cap | $29.53B |
| P/E TTM | 30.98 |
| 52w Range | Low $113.07 | High $154.27 |
| Weighted Fair Value | $132.71 |
Red Flag + AI Disruption Risk
RED FLAG: ABSENT
No imminent fatal risks are identified: the balance sheet structure is solid, liquidity is adequate (cash $1.48B, short-term debt $0.53B), and no governance or solvency issues emerge. Monitoring of post-Evoqua integration and backlog conversion timing remains prudent but does not constitute a red flag.
AI DISRUPTION RISK: LOW
Artificial intelligence is a strategic enabler for Xylem β integrated into the Xylem Vue platform for real-time optimization, sensors and predictive maintenance β and does not represent a substitution threat to water treatment and movement hardware technologies, which remain physically indispensable.
Block 1 β Objective Business Assessment
| Item | Score | Status |
|---|---|---|
| B1.1 β Leadership and systemic role | 8.50 | β Excellence |
| B1.2 β Customers and barriers to entry | 8.25 | β Excellence |
| B1.3 β Business economics | 7.75 | β Value |
| B1.4 β Balance sheet and resilience | 8.00 | β Excellence |
| Business Score | 8.13 |
B1.1 β Leadership and systemic role: 8.50
Xylem is the most complete global platform in the water technology vertical, with an extensive presence in more than 150 countries and a portfolio covering the entire water cycle: from intake to treatment, from distribution to reuse. The groupβs systemic role is structural: the water infrastructure that Xylem designs, installs and manages are critical assets for municipal utilities, heavy industry and national water security systems. The scale gained with Evoqua has made the group nearly irreplaceable in large-scale public tenders.
B1.2 β Customers and barriers to entry: 8.25
The life cycles of water plants are typically measured in decades, with multi-year maintenance and service contracts that create very high technical and relationship-based switching costs for customers. The global installed base, the regulatory certifications required to operate in municipal markets, and software integration into customersβ operating systems (Xylem Vue platform) constitute concrete barriers that are difficult for new entrants to replicate.
B1.3 β Business economics: 7.75
Xylem closed 2025 with an adjusted EBITDA margin of 22.20%, on record revenues. The transition toward service and aftermarket revenues β with higher margins and a more recurring structure β is underway and accelerating post-integration. ROE and net margin remain in line with industrial norms, with significant room for expansion from the post-M&A efficiency plan ($80-120M in annual savings announced for 2026).
B1.4 β Balance sheet and resilience: 8.00
The financial structure is orderly: limited D/E (21%), positive and growing FCF, adequate liquidity, and a proven ability to sustain significant M&A operations while maintaining financial discipline. The essential and defensive nature of the water business dampens sensitivity to adverse macroeconomic cycles.
Block 2 β Cycle & Conviction Assessment
| Item | Score | Status |
|---|---|---|
| B2.1 β Sector cycle | 7.75 | β Value |
| B2.2 β Structural trends | 8.75 | β Excellence |
| B2.3 β Competitive positioning in the cycle | 8.25 | β Excellence |
| B2.4 β Specific exogenous risks | 7.00 | β Value |
| Cycle Score | 7.94 |
B2.1 β Sector cycle: 7.75
The water infrastructure sector benefits from solid cyclical tailwinds: positive earnings estimate revisions for the industry, aggregate utility revenue growth, robust demand for upgrading obsolete networks (particularly acute in the U.S. after decades of underinvestment), expanding municipal capex, and a supportive regulatory regime β EPA PFAS rules require mandatory plant upgrades in numerous basins. The only relevant friction is sensitivity to permitting times and public funding, with the risk of contract delays. At least 4/5 positive factors: favorable cycle.
B2.2 β Structural trends: 8.75
The megatrends supporting demand for water technology are multi-decade and growing in scale: global water scarcity from climate stress, urbanization in emerging countries, the need for wastewater reuse, progressively stricter environmental standards, and exponential growth in water demand from data centers (AI cooling). The sector TAM is expanding structurally, independently of cyclical fluctuations.
B2.3 β Competitive positioning in the cycle: 8.25
With the most complete portfolio in the market (hardware, treatment, sensors, IoT software, maintenance), Xylem positions itself as a one-stop counterpart for complex public tenders. The $4.6 billion backlog at Q4 2025 β with more than 60% converting by 2026 β and MCS order growth of +22% in Q4 show operational momentum above peers.
B2.4 β Specific exogenous risks: 7.00
The main risk is a slowdown in municipal funding due to fiscal austerity or political delays in allocating infrastructure funds. Added to this are pressure on raw material costs, FX risk on international exposure, and variability in order conversion timing. No imminent binary risk.
Block 3 β Price vs Value Assessment
| Item | Score | Status |
|---|---|---|
| B3.1 β Intrinsic Fair Value | 6.05 | β οΈ Neutral |
| B3.2 β Analyst consensus | 7.26 | β Value |
| B3.3 β Relative valuation | 6.82 | β οΈ Neutral |
| B3.4 β FCF & Net Shareholder Yield | 6.60 | β οΈ Neutral |
| Price Score | 6.68 |
B3.1 β Intrinsic Fair Value: 6.05
Algorithmic fair value model estimates show moderate dispersion but conflicting directions: Alpha Spread signals overvaluation, while the other three sources indicate a slight discount. The weighted fair value is above the current price, placing XYL in the Fair Value range with a modest margin of safety.
| Source | Estimated value |
|---|---|
| ValueInvesting.io | $128.17 |
| GuruFocus | $135.03 |
| Alpha Spread | $112.50 |
| Simply Wall St | $155.15 |
The weighted fair value of $132.71 (4 sources available) places XYL at an 8.3% discount to the current price β Fair Value range. The 35.05% dispersion across sources is MIXED (Alpha Spread below price, the others above), but within the 40% threshold: no penalty applied.
> π Discount +8.3% β base score 5.92 | dispersion 35.05% MIXED β penalty 0 | Excellence Premium +0.13 (Business Score 8.13) β final score 6.05 (cap 6.50 not applied)
B3.2 β Analyst consensus: 7.26
| Analysts | Buy | Hold | Sell | Average target | Potential upside |
|---|---|---|---|---|---|
| 23 | 15 | 8 | 0 | $157.12 | +29.2% |
Sell-side consensus is constructive, with 15 Buy ratings out of 23 analysts and an average target of $157.12, ahead of the earnings release on 28 April 2026. UBSβs recent downgrade to Hold (with a $132 target) introduces a note of caution in the short term, but does not alter the bullish bias of the majority. The implied 29% upside reflects confidence in the margin expansion plan and backlog conversion.
> π Consensus (15/23 Buy) β Consensus_Score 6.52 | upside +29.2% β Upside_Score 8.00 | w = 0.50 (upside = U0) β B3.2 = 0.50 Γ 6.52 + 0.50 Γ 8.00 = 7.26
B3.3 β Relative valuation: 6.82
The 30.98x P/E TTM benefits from a favorable comparison on both axes. Versus the 5-year historical average (42.80x β inflated by periods of strong industrial multiple expansion), the stock shows a favorable gap of β27.6%, with a score of 7.10. Versus the average of peers in Machinery/Capital Goods (35.70x), the favorable gap is narrower (β13.2%), with a score of 6.53. The average of the two components points to an attractive relative valuation compared with its own history and the sector.
B3.4 β FCF & Net Shareholder Yield: 6.60
| Metric | Value |
|---|---|
| FCF TTM | $910M |
| Dividends TTM | $420M (est.) |
| Buyback TTM | ~$24M |
| FCF Yield | 3.08% |
| Dividend Yield | 1.42% |
| Buyback Yield | 0.08% |
| Net Shareholder Yield | 4.58% |
Net Shareholder Yield of 4.58% falls in the 4-6% range, indicating an overall shareholder return in line with the norm for a company in a strong post-M&A reinvestment phase. The dividend was increased by 8% in Q4 2025, signaling managementβs confidence in the FCF trajectory.
Numerical and Descriptive Summary
| Score | Value | Description |
|---|---|---|
| Business Score | 8.13 | Intrinsic business quality today |
| Cycle Score | 7.94 | Cycle, trends and future positioning |
| Price Score | 6.68 | Current price attractiveness |
Combined profile: Solid business, positive outlook, fair valuation.
Competitive Advantage and Moat
Xylemβs moat can be classified as a Wide Moat of a mixed nature: long-term technical and relationship-based switching costs on the municipal and industrial side, scale advantage in sensors and software integration (Xylem Vue platform), and regulatory know-how accumulated across water rules in dozens of jurisdictions. The moat is structurally expanding thanks to the broader post-Evoqua portfolio and the growing digitalization of services.
General Cycle and Competitive Dynamics
The water infrastructure sector is going through a decade of strong structural demand: widespread obsolescence of water networks in developed countries, emerging contaminant rules (PFAS), U.S. infrastructure funds, and climate pressure on water scarcity create a context of visible and predictable orders. Xylem distances itself from smaller competitors through its ability to respond to tenders requiring integrated hardware-software-maintenance solutions, a segment where no true rival matches its breadth.
Catalysts and Future Opportunities (Bull Case)
Backlog conversion of $4.6 billion in 2026, the full flow-through of post-Evoqua structural savings ($80-120M annually), order growth in Measurement & Control Solutions (+22% in Q4 2025), and the potential for new contracts tied to PFAS rules represent re-rating drivers over 12-24 months. Structurally, data center demand for water-cooling systems opens an additional market of growing importance.
Risks (Bear Case)
The main risk is a slowdown in municipal funding: political delays or cuts to public budgets may push back already-signed contracts or delay new tenders, affecting revenue visibility. Second, M&A dilution: slower-than-expected integration with Evoqua could compress expected margins and disappoint consensus expectations. Finally, the relative multiple β 31x P/E β offers no cushion in case of earnings misses: a scenario of slower-than-expected growth would trigger rapid repricing.
Operational Summary and Timing
Solid business, fair valuation. Limited opportunity at the current price. NEUTRAL.
Why it could be an opportunity
Xylem is the most complete flagship of the global water megatrend, with an expanding moat and a backlog that provides operational visibility. From the yearly peak ($154.27), the stock has fallen more than 21%, bringing the multiple to levels favorable relative to its own history. Earnings on 28 April 2026 could act as a stabilization catalyst if they confirm backlog conversion and maintenance of margin guidance.
Why it could be a risk
Recent price action shows pronounced weakness (-12% over the last 15 trading days), with the stock near the lows of the 52-week range. The margin of safety at the current price is positive but not wide (8.3% discount to weighted fair value). In an uncertain macro environment, sensitivity to public budgets and the risk of order delays may keep pressure on the stock before stabilization.
Price Target Table
| Level | Price | Ξ% from current | Notes |
|---|---|---|---|
| Valuation deteriorates (B3 < 6.00) | $155 | +27.4% | Price estimate for Price Score < 6.00 |
| Analyst target | $157 | +29.0% | Sell-side consensus, 23 analysts (source: TIKR/Gemini) |
| Attractive valuation (B3 β₯ 7.00) | $106 | β12.9% | Price estimate for Price Score β₯ 7.00 |
Disclaimer
This analysis is produced by the ScoreΒ³ system for informational purposes only and does not constitute financial advice, a solicitation to invest, or a trading or investment recommendation. Data is collected from public sources and may contain errors or delays. Fair value estimates and price targets are model-based projections subject to significant uncertainty and do not represent certain forecasts. Investing involves risks, including the possible loss of invested capital. Always verify critical data against primary sources before making any investment decision. Past performance is not indicative of future results.
